Absract
Imperforate hymen is a urogenital tract anomaly that represents the most frequent congenital malformation of the female genital tract. CA 19-9 and CA 125 are widely used as tumor markers, however several benign conditions are also known to increase serum CA 19-9 and CA 125 levels. According to classical textbook knowledge, imperforate hymen is not listed under the benign conditions that increase serum CA 19-9 and CA 125 levels. In this case report we describe a relation between imperforate hymen and elevated serum CA 19-9 and CA 125 levels.
Similar content being viewed by others
References
Meeina M, Severi FM, Bocchi C, Ferruci E (2004) Voluminous perinatal pelvic mass: a case of congenital hydrometrocolpos. J Maternal Fetal Neonatal Med 15:135–137
Hoskins W, Perez C, Young R, Barakat R (2005) Principles and practice of gynecologic oncology. 4th Edition, Williams and Wilkins, Lippincot pp 157–159
Sadler YW (1998) Langman’s medical embryology. 7th Edition. Williams and Wilkins, Baltimore pp 296
Satoshi I, Fumitake G (1999) Elevation of serum CA19-9 levels in benig conditions. Int Med 38(11):840–841
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buyukbayrak, E.E., Ozyapı, A.G., Karsıdag, Y.K. et al. Imperforate hymen: a new benign reason for highly elevated serum CA 19.9 and CA 125 levels. Arch Gynecol Obstet 277, 475–477 (2008). https://doi.org/10.1007/s00404-007-0493-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-007-0493-3